Description

Protirelin (TRH Thyrotropin) Peptide Vials

Introduction

Protirelin, also known as thyrotropin-releasing hormone (TRH), is a neuropeptide that plays a crucial role in regulating thyroid function. Our Protirelin (TRH Thyrotropin) Vials are specifically designed for research purposes, ensuring the highest quality for investigative studies.

Key Characteristics

These vials boast pharmaceutical-grade purity, ensuring the highest quality standards. They come in sterile packaging, providing a controlled and safe environment for experimentation. The precision formulation of the contents guarantees reliable and replicable results in research studies.

Research Applications

Protirelin (TRH Thyrotropin) Vials serve as a valuable tool for researchers in various scientific domains, including neuroscience, endocrinology, and pharmacology.

Research Benefits

TRH Thyrotropin Protirelin and Depression

Research studies have indicated a potential link between TRH Thyrotropin Protirelin and alleviation of depressive symptoms. By modulating neurotransmitter levels, Protirelin may contribute to the development of novel therapeutic approaches for depression.

TRH Thyrotropin Protirelin and Opioid Overdose

Studies suggest that Protirelin may have a role in mitigating the effects of opioid overdose. Through its impact on the central nervous system, Protirelin has shown promise in preclinical investigations as a potential adjunct in overdose management strategies.

TRH Thyrotropin Protirelin and Motor Memory

Exploring the relationship between Protirelin and motor memory, research indicates that this neuropeptide may influence the consolidation and retrieval of motor skills. Understanding these mechanisms could have implications for rehabilitation and motor learning studies.

Summary

AICAR Vials offer a valuable tool for researchers aiming to explore the diverse applications of AICAR in various scientific domains. From diabetes-related studies to investigations into brain functions and heart health, the controlled dosage provided by AICAR Vials facilitates precise experimentation.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Watanave M, Matsuzaki Y, Nakajima Y, Ozawa A, Yamada M, Hirai H. Contribution of Thyrotropin-Releasing Hormone to Cerebellar Long-Term Depression and Motor Learning. Front Cell Neurosci. 2018 Dec 12;12:490. doi: 10.3389/fncel.2018.00490. PMID: 30618637; PMCID: PMC6299015. [Read More]
2. Boghosian JD, Luethy A, Cotten JF. Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats. J Pharmacol Exp Ther. 2018 Jul;366(1):105-112. doi: 10.1124/jpet.118.248377. Epub 2018 Apr 19. PMID: 29674333; PMCID: PMC5987997. [Read More]
3. Marangell LB, George MS, Callahan AM, Ketter TA, Pazzaglia PJ, L’Herrou TA, Leverich GS, Post RM. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Arch Gen Psychiatry. 1997 Mar;54(3):214-22. doi: 10.1001/archpsyc.1997.01830150034007. PMID: 9075462. [Read More]